Your browser doesn't support javascript.
loading
Long-Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through Two Years: Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis.
McInnes, Iain B; Rahman, Proton; Gottlieb, Alice B; Hsia, Elizabeth C; Kollmeier, Alexa P; Xu, Xie L; Jiang, Yusang; Sheng, Shihong; Shawi, May; Chakravarty, Soumya D; van der Heijde, Désirée; Mease, Philip J.
Afiliación
  • McInnes IB; University of Glasgow, Glasgow, UK.
  • Rahman P; Memorial University of Newfoundland, St. Johns, Newfoundland, Canada.
  • Gottlieb AB; Icahn School of Medicine Mt. Sinai, New York, New York.
  • Hsia EC; Janssen Research & Development, Spring House, Pennsylvania, and University of Pennsylvania, Philadelphia, Pennsylvania.
  • Kollmeier AP; Janssen Research & Development, LLC, San Diego, California.
  • Xu XL; Janssen Research & Development, LLC, San Diego, California.
  • Jiang Y; Janssen Research & Development, Spring House, Pennsylvania.
  • Sheng S; Janssen Research & Development, Spring House, Pennsylvania.
  • Shawi M; Janssen Pharmaceutical Companies of Johnson & Johnson, Horsham, Pennsylvania.
  • Chakravarty SD; Janssen Scientific Affairs, Horsham, Pennsylvania, and Drexel University College of Medicine, Philadelphia, Pennsylvania.
  • van der Heijde D; Leiden University Medical Center, Leiden, The Netherlands.
  • Mease PJ; Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington.
Arthritis Rheumatol ; 74(3): 475-485, 2022 03.
Article en En | MEDLINE | ID: mdl-34719872
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Psoriásica / Antirreumáticos / Subunidad p19 de la Interleucina-23 / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Arthritis Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Psoriásica / Antirreumáticos / Subunidad p19 de la Interleucina-23 / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Arthritis Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos